Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 3, 2007, Pages 207-212

  Satoh, Katsuya ^a,b   Shirabe, Susumu ^a,b   Tsujino, Akira ^a   Eguchi, Hiroto ^a   Motomura, Masakatsu ^a   Honda, Hiroyuki ^c   Tomita, Iturou ^c   Satoh, Akira ^c   Tsujihata, Mitsuhiro ^c   Matsuo, Hidenori ^d   Nakagawa, Masanori ^e   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c Nagasaki Kita Hospital   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cerebrospinal fluid; Creutzfeldt Jakob disease; Magnetic resonance imaging

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN 14 3 3; PROTEIN S100B; TAU PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE MARKER; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION;

14-3-3 PROTEINS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CREUTZFELDT-JAKOB SYNDROME; DIFFUSION MAGNETIC RESONANCE IMAGING; ELECTROENCEPHALOGRAPHY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROPSYCHOLOGICAL TESTS; PHOSPHOPYRUVATE HYDRATASE; PRIONS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; S100 PROTEINS; TAU PROTEINS;

EID: 34548145386     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107082     Document Type: Article

References (7)

1. Brandel JP, Delasnerie-Laupretre N, et al: Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology 2000;54:1095-1099.
2. Otto M, Wiltfang J, et al: Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002;58:192-197.
3. Satoh K, Shirabe S, et al: 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol 2006;26:45-52.
4. Shiga Y, Miyazawa K, et al: Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443-449.
5. Collie DA, Sellar RJ, et al: MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 2001;56:726-739.
6. Young GS, Geschwind MD, et al: Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. Am J Neuroradiol 2005;26:1551-1562.
7. Mendez OE, Shang J, et al: Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3? J Neuroimaging 2003;13:147-151.